Mast cells in allergic diseases and mastocytosis
- PMID: 6293204
- PMCID: PMC1274065
Mast cells in allergic diseases and mastocytosis
Abstract
Mast cells with their stores of vasoactive and chemotactic mediators are central to the pathogenesis of allergic diseases. The cross-linking of receptorbound IgE molecules on the surface of mast cells initiates a complex chain of events, including calcium ion influx, phospholipid methylation and turnover and cyclic nucleotide metabolism, ultimately resulting in the release of mediators of immediate hypersensitivity. These mast cell mediators are important in smooth muscle reactivity, in the recruitment of eosinophilic and neutrophilic leukocytes and in the generation of secondary chemical mediators. Histologic evidence of mast cell degranulation, biochemical evidence of mast cell mediators in blood and tissues and clinical evidence of signs and symptoms reproducible by these mediators have strongly supported the crucial role of mast cells in asthma, urticaria, anaphylaxis, rhinitis and mastocytosis. Because of their unique location at host environment interfaces, mast cells may both participate in allergic diseases and promote homeostasis.
Similar articles
-
The mast cell in allergic disorders.Acta Otorhinolaryngol Belg. 1979;33(4):539-55. Acta Otorhinolaryngol Belg. 1979. PMID: 94232 Review. No abstract available.
-
Pediatric Expression of Mast Cell Activation Disorders.Immunol Allergy Clin North Am. 2018 Aug;38(3):365-377. doi: 10.1016/j.iac.2018.04.009. Epub 2018 May 21. Immunol Allergy Clin North Am. 2018. PMID: 30007457 Review.
-
Mast cell-IgE-and mast cell-structural cell interactions in allergic airway disease.Curr Drug Targets Inflamm Allergy. 2003 Dec;2(4):303-12. doi: 10.2174/1568010033484016. Curr Drug Targets Inflamm Allergy. 2003. PMID: 14561149 Review.
-
Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.Allergy. 2013 Feb;68(2):195-203. doi: 10.1111/all.12077. Epub 2012 Dec 18. Allergy. 2013. PMID: 23253152
-
[Mastocytosis--mastcell proliferative disease risk of anaphylactic reaction].Pol Merkur Lekarski. 2006 Dec;21(126):570-2. Pol Merkur Lekarski. 2006. PMID: 17405300 Review. Polish.
Cited by
-
Inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on compound 48/80-induced gastric mucosal lesions in rats.Agents Actions. 1994 Mar;41(1-2):21-4. doi: 10.1007/BF01986388. Agents Actions. 1994. PMID: 7521568
-
Rab46: a novel player in mast cell function.Discov Immunol. 2023 Dec 22;3(1):kyad028. doi: 10.1093/discim/kyad028. eCollection 2024. Discov Immunol. 2023. PMID: 38567292 Free PMC article.
-
Systemic mastocytosis: case report and literature review.J Natl Med Assoc. 1984 May;76(5):469-73. J Natl Med Assoc. 1984. PMID: 6737504 Free PMC article.
-
Identifying patients at risk of anaphylaxis.World Allergy Organ J. 2024 Jun 11;17(6):100904. doi: 10.1016/j.waojou.2024.100904. eCollection 2024 Jun. World Allergy Organ J. 2024. PMID: 38966605 Free PMC article. Review.
-
Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice.Immun Inflamm Dis. 2018 Mar;6(1):117-127. doi: 10.1002/iid3.204. Epub 2017 Nov 3. Immun Inflamm Dis. 2018. PMID: 29105371 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical